PRODUCT USE IN COUNTRY WHERE PRODUCT IS UNAPPROVED

This adverse event was reported 3 times

PRODUCT USE IN COUNTRY WHERE PRODUCT IS UNAPPROVED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TOVORAFENIB 1 0.0031
1 AVUTOMETINIB POTASSIUM AND DEFACTINIB HYDROCHLORIDE 1 0.0009
2 TAPENTADOL HYDROCHLORIDE 1 0.0000
3 DOCUSATE SODIUM 1 0.0000
4 FENTANYL 1 0.0000
5 PREGABALIN 1 0.0000
6 ACETAMINOPHEN 1 0.0000
See all drugs enriched for association with PRODUCT USE IN COUNTRY WHERE PRODUCT IS UNAPPROVED

These drug classes are most commonly taken by patients reporting PRODUCT USE IN COUNTRY WHERE PRODUCT IS UNAPPROVED:

# Drug class Count
0 Kinase Inhibitor [EPC] 1
1 Nonsteroidal Anti-inflammatory Drug [EPC] 1
2 Opioid Agonist [EPC] 1
See all common drug classes associated with PRODUCT USE IN COUNTRY WHERE PRODUCT IS UNAPPROVED

PRODUCT USE IN COUNTRY WHERE PRODUCT IS UNAPPROVED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Opioid Agonist [EPC] 1 0.0000
1 Kinase Inhibitor [EPC] 1 0.0000
2 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000
See all drug classes enriched for association with PRODUCT USE IN COUNTRY WHERE PRODUCT IS UNAPPROVED